Product Reports Resources Pricing Login Book a demo

Teladoc

Health Tech & Medtech · New York City, United States · Founded 2002 · IPO 2015

Provides virtual healthcare services, enabling patients to access medical professionals remotely via phone, video, or app

Valuation $1.48B
Revenue $2.44B
EBITDA $279M
Power Law Unicorn$1–10B valuation tier Thoroughbred$100M+ revenue
Knowledge graph
News Plotsy raises $1.5M seed to turn novels into cinematic streaming series Aug 12, 2026 Market map Global Metabolic Health startups (Health)

Talent graph

Teladoc's talent

Book a demo to see the people
Employees mapped 5,288 incl. 96 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 14 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Teladoc's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Trident Capital
Series A 4 investors entered at this stage
Kleiner Perkins
HLM Venture Partners
Cardinal Partners
New Capital Partners
Series B+ 5 investors entered at this stage
QuestMark Partners
Mellon Ventures
Greenspring Associates
Icon Ventures
FLAG Capital Management

Global footprint

Where Teladoc has talent and traffic

Workforce by country
🇺🇸 United States · New York City HQ
Book a demo for the full country breakdown
Web traffic by country
1M monthly visits
across markets
🇺🇸 United States88.6%
🇮🇳 India2.2%
🇨🇦 Canada1.8%
🇪🇸 Spain0.8%
🇲🇽 Mexico0.7%
Top 5 markets shown

Patent intelligence

$50M patent portfolio · 50 active families

Estimated portfolio value
$50M
3.4% of market cap · 1.7× larger than top peer Hims and Hers Health ($29M)
50 active patent families
Where Teladoc innovates Medical treatmentMobile robotReal-time computingRemote controlRobotic systems

Where Teladoc concentrates vs peers

Each axis is a top-10 topic across Teladoc and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Teladoc's 15 investments and acquisitions.

Every disclosed deal where Teladoc appeared as a backer or acquirer, 2013–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

15 deals across Teladoc's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Teladoc deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Teladoc's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        15 of 15 deals

        Market sentiment

        What the market is saying about Teladoc

        An AI-synthesized read of the highest-engagement posts about Teladoc on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Teladoc on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles